Significance of anti-Mi2 antibodies in polymyositis (PM) and dermatomyositis (DM).

被引：0
|
作者：
Roux, S
Palazzo, E
Moosbrugger, I
Haim, T
Hayem, G
Renz, M
Hachulla, E
Kahn, MF
Seelig, HP
Meyer, O
机构：
[1] HOP BICHAT,F-75877 PARIS,FRANCE
[2] CLAUDE HURIEZ HOSP,LILLE,FRANCE
[3] INST IMMUNOL & MOL GENET,KARLSRUHE,GERMANY
来源：
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：702 / 702
页数：1
相关论文
共 50 条
  • [41] Polymyositis (PM) and dermatomyositis (DM) can be genetically discriminated by HLA-DRB1 genotyping.
    Chinoy, H
    Salway, F
    Thomson, W
    Silman, AJ
    Ollier, WER
    Cooper, RG
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S397 - S397
  • [42] Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis
    Kubo, M
    Ihn, H
    Yazawa, N
    Sato, S
    Kikuchi, K
    Tamaki, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (05) : 711 - 715
  • [43] Comment on "Systematic retrospective study on 64 patients anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy"
    Lim, Johan
    Raaphorst, Joost
    van der Kooi, Anneke J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : E459 - E460
  • [44] Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis
    Lin Liang
    Ya-Mei Zhang
    He Chen
    Li-Fang Ye
    Shan-Shan Li
    Xin Lu
    Guo-Chun Wang
    Qing-Lin Peng
    European Journal of Dermatology, 2020, 30 : 151 - 158
  • [45] Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis
    Liang, Lin
    Zhang, Ya-Mei
    Chen, He
    Ye, Li-Fang
    Li, Shan-Shan
    Lu, Xin
    Wang, Guo-Chun
    Peng, Qing-Lin
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (02) : 151 - 158
  • [46] Clinical difference of interstital lung disease patients positive for anti-amnioacyl-tRNA (ARS) synthetase antibodies between dermatomyositis/polymyositis (PM/DM) group and non-myosits group
    Momose, M.
    Arita, M.
    Ishida, T.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [47] Anti-Mi-2 dermatomyositis with ulcerative plaques
    David Palacios-Diaz, Rodolfo
    Abril-Perez, Carlos
    Estebanez, Andrea
    Gegundez-Hernandez, Hector
    Angel Navarro-Mira, Miguel
    Botella-Estrada, Rafael
    RHEUMATOLOGY, 2022, 61 (10) : E326 - E327
  • [48] Pathologic Features of Anti-Mi-2 Dermatomyositis
    Tanboon, Jantima
    Inoue, Michio
    Hirakawa, Shinya
    Tachimori, Hisateru
    Hayashi, Shinichiro
    Noguchi, Satoru
    Suzuki, Shigeaki
    Okiyama, Naoko
    Fujimoto, Manabu
    Nishino, Ichizo
    NEUROLOGY, 2021, 96 (03) : E448 - E459
  • [49] CAPILLAROSCOPIC PATTERNS IN PATIENTS WITH SYSTEMIC SCLEROSIS-POLYMYOSITIS/DERMATOMYOSITIS (SSc-PM/DM) OVERLAP SYNDROME
    Desinova, O.
    Starovoytova, M.
    Ananyeva, L. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1248 - 1248
  • [50] Long-term outcome of patients with polymyositis/dermatomyositis and anti-PM-Scl antibody
    Marie, I.
    Lahaxe, L.
    Benveniste, O.
    Delavigne, K.
    Adoue, D.
    Mouthon, L.
    Hachulla, E.
    Constans, J.
    Tiev, K.
    Diot, E.
    Levesque, H.
    Boyer, O.
    Jouen, F.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (02) : 337 - 344
12345